Kathleen L. Grady

Kathleen L. Grady

Auto-generated profile, based on publicly available information

Kathleen L. Grady

Northwestern University, Department of Surgery, Division of Cardiac Surgery, Chicago, IL

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
MCMina K. Chung
Mina K. Chung
AFAngela Fagerlin
Angela Fagerlin
PWPaul J. Wang
Paul J. Wang
TATinuola B. Ajayi
Tinuola B. Ajayi
LALarry A. Allen
Larry A. Allen
JWJennifer M. Wright
Jennifer M. Wright
Shared decision making (SDM) has been advocated to improve patient care, patient decision acceptance, patient-provider communication, patient motivation, adherence, and patient reported outcomes. Documentation of SDM is endorsed in several society guidelines and is a condition of reimbursement for selected cardiovascular and cardiac arrhythmia procedures. However, many clinicians argue that SDM already occurs with clinical encounter discussions or the process of obtaining informed consent and note the additional imposed workload of using and documenting decision aids without validated tools or evidence that they improve clinical outcomes. In reality, SDM is a process and can be done without decision tools, although the process may be variable. Also, SDM advocates counter that the low-risk process of SDM need not be held to the high bar of demonstrating clinical benefit and that increasing the quality of decision making should be sufficient. Our review leverages a multidisciplinary group of experts in cardiology, cardiac electrophysiology, epidemiology, and SDM, as well as a patient advocate. Our goal is to examine and assess SDM methodology, tools, and available evidence on outcomes in patients with heart rhythm disorders to help determine the value of SDM, assess its possible impact on electrophysiological procedures and cardiac arrhythmia management, better inform regulatory requirements, and identify gaps in knowledge and future needs.

1 December 2019 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
KGKathleen L. Grady
Kathleen L. Grady
AAAdin-Cristian Andrei
Adin-Cristian Andrei
TSTamara Shankel
Tamara Shankel
RCRichard Chinnock
Richard Chinnock
SMShelley D. Miyamoto
Shelley D. Miyamoto
EPElfriede Pahl
Elfriede Pahl

20 July 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KGKathleen L. Grady
Kathleen L. Grady
PFPariya L. Fazeli
Pariya L. Fazeli
JKJames K. Kirklin
James K. Kirklin
SPSalpy V. Pamboukian
Salpy V. Pamboukian
CWConnie White‐Williams
Connie White‐Williams
Background: Factors related to health‐related quality of life (HRQOL) 2 years after left ventricular assist device (LVAD) implantation are unknown. We sought to determine whether preimplant intended goal of LVAD therapy (heart transplant candidate [short‐term group], uncertain heart transplant candidate [uncertain group], and heart transplant ineligible [long‐term group]) and other variables were related to HRQOL 2 years after LVAD implantation. Methods and Results: Our LVAD sample (n=1620) was from INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Using the EuroQol‐5 Dimension Questionnaire (EQ‐5D‐3L), a generic HRQOL measure, and the Kansas City Cardiomyopathy Questionnaire (KCCQ‐12), a heart failure–specific HRQOL measure, multivariable linear regression modeling was conducted with the EQ‐5D‐3L Visual Analog Scale (VAS) score and KCCQ‐12 overall summary score (OSS) as separate dependent variables. Two years after LVAD implant, the short‐term group had a significantly higher mean VAS score versus the uncertain and long‐term groups (short‐term: 75.18 [SD, 20.62]; uncertain: 72.27 [SD, 20.33]; long‐term: 70.87 [SD, 22.09], P =0.01); differences were not clinically meaningful. Two‐year mean scores did not differ by group for the KCCQ‐12 OSS (short‐term, 67.85 [SD, 20.61]; uncertain, 67.79 [SD, 19.31]; long‐term, 67.08 [SD, 21.49], P =0.80). Factors associated with a worse VAS score 2 years postoperatively (n=1205) included not working; not having a short‐term LVAD; and postoperative neurological dysfunction, greater health‐related stress, coping poorly, less VAD self‐care confidence, and less satisfaction with VAD surgery, explaining 28% of variance ( P <0.001). Factors associated with a worse KCCQ‐12 OSS 2 years postoperatively (n=1250) included not working; history of high body mass index and diabetes mellitus; and postoperative renal dysfunction, greater health‐related stress, coping poorly, less VAD self‐care confidence, less satisfaction with VAD surgery, and regret regarding VAD implantation, accounting for 36% of variance ( P <0.001). Conclusions: Factors related to HRQOL 2 years after LVAD implantation include demographic, clinical, and psychological variables.

3 November 2017 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
KGKathleen L. Grady
Kathleen L. Grady
KHKathleen Van’t Hof
Kathleen Van’t Hof
AAAdin-Cristian Andrei
Adin-Cristian Andrei
TSTamara Shankel
Tamara Shankel
RCRichard Chinnock
Richard Chinnock
EPElfriede Pahl
Elfriede Pahl

1 December 2017 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
PDF file
KGKathleen L. Grady
Kathleen L. Grady
PJPhilip G. Jones
Philip G. Jones
ACAdin Cristian-Andrei
Adin Cristian-Andrei
DNDavid C. Naftel
David C. Naftel
SMSusan Myers
Susan Myers
JSJohn A. Spertus
John A. Spertus
Background—: Missing health-related quality of life (HRQOL) data in longitudinal studies can reduce precision and power and bias results. Using INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support), we sought to identify factors associated with missing HRQOL data, examine the impact of these factors on estimated HRQOL assuming missing at random missingness, and perform sensitivity analyses to examine missing not at random (MNAR) missingness because of illness severity. Methods and Results—: INTERMACS patients (n=3248) with a preimplantation profile of 1 (critical cardiogenic shock) or 2 (progressive decline) were assessed with the EQ-5D-3L visual analog scale and Kansas City Cardiomyopathy Questionnaire-12 summary scores pre-implantation and 3 months postoperatively. Mean and median observed and missing at random–imputed HRQOL scores were calculated, followed by sensitivity analyses. Independent factors associated with HRQOL scores and missing HRQOL assessments were determined using multivariable regression. Independent factors associated with preimplantation and 3-month HRQOL scores, and with the likelihood of missing HRQOL assessments, revealed few correlates of HRQOL and missing assessments ( R 2 range, 4.7%–11.9%). For patients with INTERMACS profiles 1 and 2 and INTERMACS profile 1 alone, missing at random–imputed mean and median HRQOL scores were similar to observed scores, before and 3 months after implantation, whereas MNAR-imputed mean scores were lower (≥5 points) at baseline but not at 3 months. Conclusions—: We recommend use of sensitivity analyses using an MNAR imputation strategy for longitudinal studies when missingness is attributable to illness severity. Conduct of MNAR sensitivity analyses may be less critical after mechanical circulatory support implant, when there are likely fewer MNAR data.

1 July 2007 in Patient Education and Counseling
Verified
Journal Article
Closed access
SGSarah J. Goodlin
Sarah J. Goodlin
RTRobin Trupp
Robin Trupp
PBPaul Bernhardt
Paul Bernhardt
KGKathleen L. Grady
Kathleen L. Grady
KDKathleen Dracup
Kathleen Dracup